MLL2 mosaic mutations and intragenic deletion-duplications in patients with Kabuki syndrome

S Banka1, E Howard, S Bunstone

  • 1Department of Genetic Medicine, St Mary's Hospital, Manchester Academic Health Sciences Centre (MAHSC), University of Manchester, Manchester, UK. Siddharth.Banka@manchester.ac.uk

Clinical Genetics
|August 21, 2012
PubMed

Insights

Kabuki syndrome (KS) is a rare genetic disorder. Researchers identified novel MLL2 gene mutations in five patients, expanding the known genetic causes of KS.

Area of Science:

  • Genetics
  • Molecular Biology
  • Developmental Biology

Background:

  • Kabuki syndrome (KS) is a rare genetic disorder characterized by congenital malformations, distinctive facial features, and developmental delays.
  • Mutations in the MLL2 gene are the primary cause of KS, accounting for the majority of diagnosed cases.
  • A significant portion of KS cases remain genetically unsolved, indicating the need for broader diagnostic approaches.

Observation:

  • This study investigated five patients with clinically diagnosed Kabuki syndrome.
  • All five patients presented with novel types of mutations within the MLL2 gene, including mosaic deletions and duplications.
  • These mutations were not detectable through standard sequencing methods.

Findings:

  • The study identified previously unreported MLL2 mutation types in Kabuki syndrome patients, including mosaic small deletions, whole-gene deletions, multi-exon deletions, and multi-exon duplications.
  • These findings highlight the importance of considering MLL2 gene dosage abnormalities in KS diagnosis.
  • The prevalence of these complex MLL2 mutations may be significant, potentially rivaling that of KDM6A deletions.

Implications:

  • The discovery of novel MLL2 mutation types expands the genetic understanding of Kabuki syndrome.
  • Recommending MLL2 dosage studies for unsolved KS cases can improve diagnostic yield.
  • Further research into these MLL2 mutations will elucidate disease mechanisms and inform potential therapeutic strategies.